Cognizant price target raised to $80 from $75 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Cognizant (CTSH) to $80 from $75 and keeps an Equal Weight rating on the shares while ...
Gilead Sciences, Inc. (GILD): AI Partnerships Enhancing Biopharmaceutical Advancements
We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...
Pharmabiz10h
Cognizant and Gilead expand partnership to drive greater value through advanced technology applications
Cognizant and Gilead expand partnership to drive greater value through advanced technology applications: Teaneck, New Jersey Friday, January 31, 2025, 14:00 Hrs [IST] Cognizant ha ...
Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD)
Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...